Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: ₹0.2 M
• Last 3 months FTD volume: ₹4.03 M
• Last year FTD volume: ₹4.03 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx Pharmaceutical RARE	₹1.4 M	₹5.53 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	₹1.7 M	₹23.6 M	🇺🇸 USA
Pfizer PFE	₹32.79 M	₹0.34 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	₹25.08 M	₹50.67 M	🇺🇸 USA
Amicus Therapeutics FOLD	₹0.84 M	₹5 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	₹2.32 M	₹9.26 M	🇺🇸 USA